Bioactivx

Bioactivx is a biotech company in Singapore, Singapore, founded in 2023. It has raised $1.4M across 1 round, most recently a $1.4M Seed in November 2025.

Advanced wound care for faster, scarless healing.

Headquarters
Singapore
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$1.4M
Last Round
$1.4M SeedNov 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Bioactivx is a Singapore-based regenerative medicine and biomaterials startup developing fully synthetic, animal-free wound care implants that accelerate healing and reduce infection risk. Founded in 2023 as an A*STAR spin-off by Dr. Peili Teo, Dr. Yew Lok Woo, and Mickey Cheong, the company's proprietary biomaterial platform technology creates medical implants that actively support the body's natural healing process. Its flagship product, the Bioactiv Matrix, is a next-generation skin substitute designed to close both acute and chronic wounds — including burns, ulcers, cuts, and abrasions — by promoting skin regeneration and controlling inflammation. The pipeline includes Bioactiv Foam, antimicrobial foam and cellulose, and a surgical wound closure device. Currently at the seed stage and preparing for regulatory submission, Bioactivx is backed by 8 publications, 24 patents filed, 4 patents granted, and 17 preclinical trials. In November 2025 the company raised a USD 1.425M seed round. Its mission is to improve healing outcomes and enhance patient quality of life through innovative regenerative medical implants.

Summary

It lists 1–10 employees. It has raised $1.4M in total across 1 round, most recently a $1.4M Seed round in Nov 2025. Investors include Cocoon Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundNov 2025
$1.4M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bioactivx on Indexed.vc
<a href="https://indexed.vc/companies/bioactivx"><img src="https://indexed.vc/api/badge/company/bioactivx" alt="Bioactivx on Indexed.vc" width="260" height="76" /></a>